Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

IBALIZUMAB-UIYK: Who Reports Side Effects? Age, Gender & Country Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

Gender Distribution

22.8%
Female
77.2%
Male

Age Information

The average age of patients reporting adverse events with IBALIZUMAB-UIYK is 56.0 years.

Geographic Distribution

The majority of adverse event reports for IBALIZUMAB-UIYK originate from US.

Report Summary & Outcomes

418
Total Reports
418
As Primary/Secondary Suspect
31
Deaths Reported
94
Hospitalizations
3
Life-Threatening
2
Disabilities

Reporting Timeline

First adverse event report: 2018. Most recent report: 20250306. View full timeline →

More About IBALIZUMAB-UIYK

IBALIZUMAB-UIYK Full Profile Reports by Year Drug Interactions